½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting

      »¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

      021-54845833/15800441009

      Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

      µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > ¿ÆÑп¹Ìå > Ò»¿¹ > Íÿ¹B4GALNT2¶à¿Ë¡¿¹Ìå

      ²úÆ·ÖÐÐÄ

      ×îвúÆ·

      • Íÿ¹B4GALNT2¶à¿Ë¡¿¹Ìå

        ¹æ¸ñ£º
        ¼Û¸ñ£º£¤
        • Æ·ÅÆ : ͨεÉúÎï
        • Ŀ¼ºÅ : TW3059
        • Ó¦Óà : ½öÓÃÓÚ¿ÆÑÐʹÓÃ
        • »õÆÚ : ÏÖ»õ
        • ¹æ¸ñ £º100ul/200ul/25ul
      • ÉÌÆ·ÏêÇé
      • ²Î¿¼ÎÄÏ×
      • ˵Ã÷ÊéÏÂÔØ
      • ÉÌÆ·ÆÀÂÛ0
      • Ïà¹Ø²úÆ·

      ÖÐÎÄÃû³Æ£ºÍÿ¹B4GALNT2¶à¿Ë¡¿¹Ìå

      Ó¢ÎÄÃû³Æ£º Anti-B4GALNT2 rabbit polyclonal antibody

      ±ð      Ãû£º B4GALT; GALGT2

      Ïà¹ØÀà±ð£º Ò»¿¹

      ´¢      ´æ£º Àä¶³£¨-20¡æ£©

      ËÞ      Ö÷£º Rabbit

      ¿¹      Ô­£º B4GALNT2

      ·´Ó¦ÖÖÊô£º Human

      ±ê ¼Ç Î Unconjugate

      ¿Ë¡ÀàÐÍ£º rabbit polyclonal

      ¼¼Êõ¹æ¸ñ

      Background:

      B4GALNT2 catalyzes the last step in the biosynthesis of the human Sd(a) antigen through the addition of an N-acetylgalactosamine residue via a beta-1,4 linkage to a subterminal galactose residue substituted with an alpha-2,3-linked sialic acid. B4GALNT2 also catalyzes the last step in the biosynthesis of the Cad antigen (Montiel et al., 2003 [PubMed 12678917]).

      Applications:

      ELISA, IHC

      Name of antibody:

      B4GALNT2

      Immunogen:

      Fusion protein of human B4GALNT2

      Full name:

      beta-1,4-N-acetyl-galactosaminyltransferase 2

      Synonyms:

      B4GALT; GALGT2

      SwissProt:

      Q8NHY0

      ELISA Recommended dilution:

      5000-10000

      IHC positive control:

      Human liver cancer

      IHC Recommend dilution:

      30-150





      ¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿


      ¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿